PROF Financials

Income Statement
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Revenue
5.3M
-10.7%
6.0M
+13.0%
5.3M
+139.2%
2.2M
-15.6%
2.6M
Cost of Revenue
1.5M
-24.2%
2.0M
+46.2%
1.4M
+129.0%
593.0K
-22.8%
768.0K
Gross Profit
3.8M
-4.0%
4.0M
+1.5%
3.9M
+143.0%
1.6M
-12.7%
1.9M
Operating Expenses
11.9M
+4.3%
11.4M
-11.6%
12.8M
-16.7%
15.4M
+18.5%
13.0M
R&D
5.3M
+23.2%
4.3M
-21.2%
5.4M
-11.2%
6.1M
+26.8%
4.8M
SG&A
6.6M
-7.0%
7.1M
-4.6%
7.4M
-20.4%
9.3M
+13.6%
8.2M
Operating Income
-8021000
-8.8%
-7369000
+17.3%
-8913000
+35.4%
-13806000
-23.6%
-11166000
EBITDA
-7921000
-9.1%
-7260000
+17.2%
-8766000
+35.9%
-13665000
-24.2%
-11003000
Net Income
-7053000
+13.7%
-8175000
-2.5%
-7977000
+49.2%
-15695000
-46.4%
-10724000
EPS (Basic)
$-0.19
+29.6%
$-0.27
-3.8%
$-0.26
+50.0%
$-0.52
-44.4%
$-0.36
EPS (Diluted)
$-0.19
+29.6%
$-0.27
-3.8%
$-0.26
+50.0%
$-0.52
-44.4%
$-0.36
Shares (Diluted)
36.3M
+18.1%
30.7M
+2.1%
30.1M
+0.2%
30.1M
+0.0%
30.0M
Profound Medical (PROF) โ€” Financials